Single-dose effects on the P3no-go ERP component predict clinical response to stimulants in pediatric ADHD
Open Access
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Clinical Neurophysiology
- Vol. 127 (10) , 3277-3287
Abstract
No abstract availableKeywords
Funding Information
- Østfold Hospital Trust
This publication has 52 references indexed in Scilit:
- The Attention System of the Human Brain: 20 Years AfterAnnual Review of Neuroscience, 2012
- The Pharmacology and Clinical Outcomes of Amphetamines to Treat ADHDCNS Drugs, 2012
- Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity DisorderThe Journal of Neuroscience, 2012
- Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteersPsychopharmacology, 2011
- Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidatePsychopharmacology, 2011
- Executive Impairment Determines ADHD Medication Response: Implications for Academic AchievementJournal of Learning Disabilities, 2011
- Schedule for affective disorders and schizophrenia for school-age children (K-SADS-PL) for the assessment of preschool children – A preliminary psychometric studyJournal of Psychiatric Research, 2009
- Attention-deficit/hyperactivity disorder: Use of cognitive evoked potential (P300) to predict treatment responseClinical Neurophysiology, 2006
- Attention deficit/hyperactivity disorder: characteristics, interventions and modelsNeurotoxicology and Teratology, 2000
- TEST REVIEW Behavior Rating Inventory of Executive FunctionChild Neuropsychology, 2000